We investigated the AIM1 expression pattern in a cohort of 104 patients, from whom 81 morphologically benign prostate sections, 87 sections of prostate adenocarcinoma of various Gleason grades, and 52 lymph-node metastases were examined (Fig. 8a, b, Table 3, Supplementary Fig. 4F). The gene discussed is CRYBG1; the disease is prostate adenocarcinoma.